Financial
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
InterSystems
HQ United States · North America
Directory listing. Financial health and risk summaries come from public sources only (see below); products have not been catalogued yet. Source: HSH editorial list from public company information, November 2026 — awaiting verification.
At a glance
Financial health
Band: Not assessed
Customer rating
No reviews yet
Financial health
Band: Not assessedPrivately held
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Band from the latest full-year operating margin in official results: 10% or more Strong, 0–10% Fair, below 0 Weak. Where operating profit is not published, the stated alternative margin is used. Not assessed means no usable public figures.
Products & services
Products not yet catalogued.
Risk summary
Full risk page with sources →Researched 8 Nov 2026
Adverse media
No adverse media (lawsuits, regulator action, misconduct or restructuring) involving InterSystems found in HSH's search of the last 24 months.
Cyber & information governance
Apr 2025: InterSystems published a security notification on vulnerabilities affecting OAuth2 client configurations in IRIS, HealthShare, TrakCare, Caché and Ensemble, with remediation via its support centre. NHS DSPT status not yet checked.
Regulatory & clinical safety
No product recalls, safety notices or clinical safety incidents involving InterSystems found in HSH's search of the last 24 months.
Contract performance
Oct 2025: The Royal Orthopaedic Hospital NHS Foundation Trust selected InterSystems TrakCare as its EPR after a procurement, with the programme due to begin in 2026.
Competitors
No competitors linked yet.